8-K
DocGo Inc. (DCGO)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):June 20, 2022
DOCGO INC.
(Exact name of registrant as specified in itscharter)
| Delaware | 001-39618 | 85-2515483 |
|---|---|---|
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 35West 35th Street, Floor 6, New York, New York | 10001 | |
| --- | --- | |
| (Address of principal executive offices) | (Zip Code) |
(844) 443-6246
(Registrant’s telephone number, includingarea code)
N/A
(Former name or former address, if changed sincelast report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common stock, par value $0.0001 per share | DCGO | The Nasdaq Stock Market LLC |
| Warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share | DCGOW | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item5.07 Submission of Matters to a Vote ofSecurity Holders
On Monday, June 20, 2022, DocGo Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders (the “Annual Meeting”) at 12:00 p.m. Eastern Time. As of the close of business on April 25, 2022, the record date for the Annual Meeting, there were 100,345,233 shares of common stock entitled to vote at the Annual Meeting. The results of the matters voted upon at the Annual Meeting were as follows:
| 1. | Election of the three Class I director nominees to serve until the 2025 Annual Meeting of Stockholders or until their successors are<br>duly elected and qualified (Proposal 1): | ||
|---|---|---|---|
| Director Nominee | Votes For | Votes Withheld | Broker Non-Votes |
| --- | --- | --- | --- |
| Mr. Stan Vashovsky | 64,326,840 | 4,192,954 | 10,740,882 |
| Mr. Ira Smedra | 63,128,684 | 5,391,110 | 10,740,882 |
| Mr. Ely D. Tendler | 63,880,550 | 4,639,244 | 10,740,882 |
| 2. | Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm<br>for the year ending December 31, 2022 (Proposal 2): | ||
| --- | --- | ||
| Votes For | Votes Against | Abstentions | Broker Non-Votes |
| --- | --- | --- | --- |
| 79,160,326 | 38,061 | 62,289 | — |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| DOCGO INC. | |
|---|---|
| By: | /s/<br> Andre Oberholzer |
| Name: Andre Oberholzer | |
| Title: Chief Financial Officer |
Date: June 22, 2022
2